Carl DeSelm, MD, Radiation Oncology, Saint Louis, MO

CarlJDeSelmMDPhD

Radiation Oncology Saint Louis, MO

Assistant Professor

Dr. DeSelm is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. DeSelm's full profile

Already have an account?

  • Office

    Washington University in St. Louis
    Center for Human Immunotherapy and Immunology
    Saint Louis, MO 63108
  • Is this information wrong?

Summary

  • Carl DeSelm Lab

    Developing cellular immunotherapies for difficult cancers.

Education & Training

  • Memorial Sloan-Kettering Cancer Center
    Memorial Sloan-Kettering Cancer CenterFellowship, Translational Research, 2017 - 2018
  • Memorial Sloan-Kettering Cancer Center
    Memorial Sloan-Kettering Cancer CenterResidency, Radiation Oncology, 2013 - 2017
  • Washington University
    Washington UniversityInternship, Internal Medicine, 2012 - 2013
  • Washington University School of Medicine in St. Louis
    Washington University School of Medicine in St. LouisClass of 2012

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2020 - 2023
  • MO State Medical License
    MO State Medical License 2018 - 2022
  • NY State Medical License
    NY State Medical License 2013 - 2019
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • Agilent 2020 Early Career Professor Award Agilent, 2020
  • Early Independence Award (DP5) NIH

Publications & Presentations

PubMed

Abstracts/Posters

  • Early Experience Using Radiotherapy As a Salvage Treatment for Relapsed or Refractory Non-Hodgkin Lymphomas Following CD19 Chimeric Antigen Receptor Modified T-Cell Th...
    Carl DeSelm, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • MSKCC Early Experience Using Radiotherapy As a Bridging Strategy for Relapsed Diffuse Large B Cell Lymphoma before CD19 CAR T Therapy
    Carl DeSelm, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

  • Telluride Alum Receives Prestigious Honor
    Telluride Alum Receives Prestigious HonorOctober 23rd, 2020

Grant Support

  • The Role Of Paxillin In The OsteoclastNational Institute On Aging2009–2011